In other countries
The same active substances on other registers, the same brand first.
- NovoSevenEuropean Union · Novo Nordisk A/SSame brand
- NovoSevenCroatiaSame brand
- NovosevenItaly · Polvere e solvente per soluzione iniettabile · Novo Nordisk A/SSame brand
- NovoSeven 1 mg (50 KIE) poeder en oplosmiddel voor oplossing voor injectieNetherlands · Poeder en oplosmiddel voor oplossing voor injectie · Novo Nordisk A.S.Same brand
- NovoSeven 2 mg (100 KIE) poeder en oplosmiddel voor oplossing voor injectieNetherlands · Poeder en oplosmiddel voor oplossing voor injectie · Novo Nordisk A.S.Same brand
- NovoSeven 5 mg (250 KIE) poeder en oplosmiddel voor oplossing voor injectieNetherlands · Poeder en oplosmiddel voor oplossing voor injectie · Novo Nordisk A.S.Same brand
- NOVOSEVEN 1 mg (50 KUI)Romania · 50 KIU · pulb. + solv. pt. sol. inj. · Novo Nordisk A/SSame brand
- NovoSeven®Serbia · 1mg · prašak i rastvarač za rastvor za injekciju · Novo Nordisk Pharma DOO BeogradSame brand
- NovoSeven® powder and solvent for solution for injection 1mgSingapore · 1mg · injection, powder, for solution · Novo Nordisk Pharma (Singapore) Pte LTDSame brand
- NovoSeven® powder and solvent for solution for injection 2mgSingapore · 2mg · injection, powder, for solution · Novo Nordisk Pharma (Singapore) Pte LTDSame brand
- Novoseven, Novoseven RtUnited States · 2.0MG · For Injection · Novo Nordisk Inc.Same brand
- Novoseven, Novoseven RtUnited States · 1.0MG · For Injection · Novo Nordisk Inc.Same brand
- Novoseven, Novoseven RtUnited States · 5.0MG · For Injection · Novo Nordisk Inc.Same brand
- CevenfactaItaly · Polvere e solvente per soluzione iniettabile · Laboratoire Francais Du Fractionnement et Des BiotechnologiesSame form
- Novo Seven 1.2MG-VialSaudi Arabia · Novo NordiskSame form
- Novo Seven 2.4MG-VialSaudi Arabia · Novo NordiskSame form
- Novo Seven 4.8MG-VialSaudi Arabia · Novo NordiskSame form
- Niastase RTCanada · 1 MG / VIAL · Kit, Powder For Solution · Novo Nordisk Canada INCSame substance
- Niastase RTCanada · 5 MG / VIAL · Kit, Powder For Solution · Novo Nordisk Canada INCSame substance
- Niastase RTCanada · 2 MG / VIAL · Kit, Powder For Solution · Novo Nordisk Canada INCSame substance
- CevenfactaEuropean Union · Laboratoire Francais du Fractionnement et des BiotechnologiesSame substance
- HemAryoEuropean Union · UGA BiopharmaSame substance
- CevenfactaCroatiaSame substance
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
New Zealand Pharmaceutical Management Agency (PHARMAC); https://schedule.pharmac.govt.nz/pub/schedule/archive/Schedule_2026-10.xml; October 2026; published 2026-10-08; acquired 2026-10-13T22:49:29.739475+00:00. XML-to-graph and conservative medicine-domain projections are adaptations. Written attribution; PHARMAC logo excluded.
Licence: CC BY 4.0; PHARMAC Pharmaceutical Schedule XML files · Added 14 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Coagulation factor viia
- Dosage form
- Inj 5 mg syringe
- Register
- New Zealand (PHARMAC)
- Status
- Funded
- Status in the register
- Funded by PHARMAC
- Procedure
- Community Pharmaceutical Schedule
- Supply
- Funded (PHARMAC)